Companies / BSX vs RMD
BSX vs RMD: Boston Scientific and ResMed
Boston Scientific (BSX) reported $20.1B in revenue against a 14.4% net margin, while ResMed (RMD) reported $5.7B at a 26.9% net margin, most recently.
| Metric | BSX | RMD |
|---|---|---|
| Revenue | $20.1B | $5.7B |
| Net Income | $2.9B | $1.5B |
| Gross Margin | 69.0% | 61.1% |
| Operating Margin | 18.0% | 33.4% |
| EPS (Diluted) | $1.94 | $10.43 |
| Free Cash Flow | $3.7B | $1.6B |
| Total Debt | $11.4B | $0.7B |
| P/E Ratio | 49.2× | 18.7× |
| P/B Ratio | n/m | 4.3× |
| Stock Price | $44.62 | $238.83 |
Free: last 5 years
| Fiscal year | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BSX Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $11.9B | $12.7B | $14.2B | $16.7B | $20.1B |
| RMD Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | — | $3.6B | $4.2B | $4.7B | $5.1B |